Medication info
Gabanyuro Sustained-Release Tablet 150 mg (Pregabalin)

Gabanyuro Sustained-Release Tablet 150 mg (Pregabalin)

Prescription medicationTablet
Ingredient · strength
Pregabalin›70mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
White to slightly yellow oblong film-coated sustained-release tablet
Packaging
30 tablets (6 tablets/PTP x 5)
Approval status
Active

MFDS item code 201900147 · Approved 2019.01.11 · Insurance code 645306000

Summary

Main use
Treatment of peripheral neuropathic pain in adults
Who uses it
Adults · Children
Adult dosage
This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
Children's dosage
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of peripheral neuropathic pain in adults

  • Peripheral neuropathic pain
View approved original text

This medication is used to relieve peripheral neuropathic pain in adults. Peripheral neuropathic pain is pain caused by nerve damage, which can significantly disrupt daily life. This drug helps improve symptoms by suppressing excessive nerve activity and reducing pain signals. Therefore, it effectively aids in lessening discomfort caused by peripheral neuropathic pain and plays an important role in improving the patient's quality of life.

Dosage and Administration

Adult dosage

This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.

Children's dosage

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Precautions

This medication may increase the risk of suicidal thoughts and behaviors, so patients should be carefully monitored for signs of depression, mood changes, or abnormal behavior during treatment. Patients allergic to pregabalin or any ingredients in this medication should not use it. Diabetic patients may need to adjust the dosage of blood sugar control medication due to weight gain. If symptoms of angioedema occur, such as swelling of the face or around the mouth, discontinue use immediately and consult a healthcare professional. Elderly patients should take special care at the beginning of treatment due to the risk of falls or injury from dizziness or drowsiness. These symptoms should be reported to a healthcare professional, as blurred vision or vision changes may occur. Abrupt discontinuation of this medication may cause withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so dosage should be gradually reduced according to a healthcare professional's instructions. Patients with a history of drug abuse may have a higher risk of abuse with this medication, thus caution is warranted. Patients with reduced kidney function may require dosage adjustments, and it should be administered cautiously to patients with severe heart failure. Concomitant use with opioid analgesics may increase the risk of central nervous system depression, so caution is advised. This medication should not be taken by pregnant women in early pregnancy due to the risk of congenital malformations in the fetus, and women of childbearing age should use effective contraception. Dizziness and drowsiness may occur during treatment, so it is advisable to avoid driving or operating hazardous machinery. Serious skin reactions may occur infrequently; if rashes or skin abnormalities appear, discontinue use immediately and consult a healthcare professional. In case of overdose, confusion, drowsiness, depression, seizures, etc., may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and should not be transferred to another container for safety.

Side effects

  • Suicidal thoughts
  • suicidal behavior
  • depression
  • abnormal changes in mood and behavior
  • angioedema
  • facial swelling
  • periorbital edema
  • upper respiratory tract edema
  • dizziness
  • drowsiness
Show 189 more
  • loss of consciousness
  • confusion
  • mental disorders
  • blurred vision
  • vision changes
  • insomnia
  • headache
  • nausea
  • diarrhea
  • influenza-like syndrome
  • restlessness
  • pain
  • seizures
  • sweating
  • withdrawal symptoms
  • weight gain
  • constipation
  • dyspepsia
  • nausea
  • dry mouth
  • vomiting
  • peripheral edema
  • bradycardia
  • palpitations
  • pruritus
  • arthralgia
  • hypoglycemia
  • rhinitis
  • hypertension
  • abdominal distention
  • increased serum creatinine phosphokinase
  • vertigo
  • ataxia
  • impaired coordination
  • balance disorders
  • amnesia
  • attention disorders
  • memory disorders
  • tremors
  • dysarthria
  • sensory abnormalities
  • sensory loss
  • sedation
  • somnolence
  • cognitive impairment
  • nystagmus
  • speech disorders
  • myoclonus
  • diminished reflexes
  • movement disorders
  • psychomotor agitation
  • orthostatic dizziness
  • hyperesthesia
  • burning sensation
  • tremor during activity
  • syncope
  • confusion
  • hypokinesia
  • hyposmia
  • loss of taste
  • writing difficulties
  • diplopia
  • indirect vision loss
  • visual disturbances
  • visual field loss
  • photophobia
  • dry eyes
  • eyelid swelling
  • decreased vision
  • eye pain
  • eye fatigue
  • increased tear secretion
  • eye irritation
  • mydriasis
  • changes in depth perception
  • strabismus
  • brightness of vision
  • vertigo
  • auditory hypersensitivity
  • first-degree AV block
  • tachycardia
  • sinus bradycardia
  • sinus tachycardia
  • sinus arrhythmia
  • hypotension
  • flushing
  • facial flushing
  • peripheral coldness
  • dyspnea
  • epistaxis
  • cough
  • nasal congestion
  • rhinitis
  • snoring
  • throat tension
  • nasal dryness
  • respiratory depression
  • excessive salivation
  • gastroesophageal reflux
  • oral sensory loss
  • ascites
  • dysphagia
  • pancreatitis
  • sweating
  • papular rash
  • urticaria
  • cold sweats
  • muscle cramps
  • back pain
  • limb pain
  • cervical spasms
  • joint swelling
  • myalgia
  • muscle twitching
  • neck pain
  • muscle rigidity
  • rhabdomyolysis
  • urinary disorders
  • urinary incontinence
  • decreased urination
  • renal failure
  • erectile dysfunction
  • delayed ejaculation
  • sexual dysfunction
  • dysmenorrhea
  • amenorrhea
  • breast pain
  • breast discharge
  • breast enlargement
  • gait abnormalities
  • falling
  • feeling intoxicated
  • sensory abnormalities
  • fatigue
  • chest tightness
  • generalized edema
  • pain
  • fever
  • chills
  • weakness
  • thirst
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • increased blood glucose
  • decreased platelet count
  • decreased serum potassium
  • increased serum creatinine
  • decreased white blood cell count
  • hypersensitivity
  • allergic reactions
  • keratitis
  • congestive heart failure
  • pulmonary edema
  • tongue swelling
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • malaise
  • fatigue
  • weakness
  • gait abnormalities
  • decreased libido
  • sleep disorders
  • insomnia
  • ataxia
  • speech difficulties
  • sensory abnormalities
  • memory disorders
  • attention disorders
  • gastrointestinal disorders
  • blood in stool
  • increased BUN
  • dysuria
  • abdominal pain
  • upper abdominal pain
  • eyelid swelling
  • cataracts
  • Bell's palsy
  • liver dysfunction
  • increased blood alkaline phosphatase
  • ear disorders
  • shock
  • anaphylactic-like symptoms
  • Stevens-Johnson syndrome
  • erythema multiforme
  • affective disorders
  • coma
  • agitation
  • restlessness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to slightly yellow oblong film-coated sustained-release tablet

Package unit

30 tablets (6 tablets/PTP x 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.